UK Charity Aims To Knock Years Off Lung Cancer Vaccine Development
Executive Summary
Having linked up with Asterias, Nigel Blackburn, Cancer Research UK’s director of drug development, tells Scrip that a pact covering the US firm's allogeneic cancer vaccine made from dendritic cells is typical of a project "that without our help could either stall or languish."